CN Patent

CN120344244A — 治疗alk阳性或ros1阳性的非小细胞肺癌的方法

Assigned to Shenzhen Targetrx Inc · Expires 2025-07-18 · 1y expired

What this patent protects

提供了通过向受试者给药化合物A或其药学上可接受的盐来治疗受试者的ALK阳性非小细胞肺癌的方法。还提供了通过向受试者给药化合物A或其药学上可接受的盐来治疗受试者的ROS1阳性非小细胞肺癌的方法。

USPTO Abstract

提供了通过向受试者给药化合物A或其药学上可接受的盐来治疗受试者的ALK阳性非小细胞肺癌的方法。还提供了通过向受试者给药化合物A或其药学上可接受的盐来治疗受试者的ROS1阳性非小细胞肺癌的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN120344244A
Jurisdiction
CN
Classification
—
Expires
2025-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Targetrx Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.